ORACLE CORP financial statements

Income statement, balance sheet and cash flow statement for the last 10 fiscal years, taken from the XBRL data ORACLE CORP files with the SEC in its annual reports.

In USD millions, except per-share amounts. Outflows in the cash flow statement are negative.

Income statement

	FY2017	FY2018	FY2019	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025	FY2026
Revenue	37,792	39,383	39,506	39,068	40,479	42,440	49,954	52,961	57,399	67,357
Cost of revenue	2,801	2,888
Gross profit	23,017	24,287
Research and development	6,153	6,084	6,026	6,067	6,527	7,219	8,623	8,915	9,860	10,272
Selling and marketing	8,085	8,433	8,509	8,094	7,682	8,047	8,833	8,274	8,651	8,331
General and administrative	1,172	1,282	1,265	1,181	1,254	1,317	1,579	1,548	1,602	1,618
Operating income	12,913	13,264	13,535	13,896	15,213	10,926	13,093	15,353	17,678	20,606
Interest expense	1,798	2,025	2,082	1,995	2,496	2,755	3,505	3,514	3,578	4,599
Interest income	804	1,203	1,092	527	101	94	285	451	578	780
Other non-operating income	605	1,237	-14	-16	211	-86	-6	168	91	309
Pre-tax income	11,517	12,891	3,774	3,890	4,375	-629	1,492	3,023	4,376	8,693
Income tax	2,228	8,837	1,185	1,928	-747	932	623	1,274	1,717	2,467
Net income to minority interests	118	135	152
Net income	9,452	3,587	11,083	10,135	13,746	6,717	8,503	10,467	12,443	17,087
EBITDA	13,913	14,429	14,765	15,278	16,750	12,898	15,619	18,482	21,545	28,229
EPS, basic	2.30	0.87	3.05	3.16	4.67	2.49	3.15	3.82	4.46	5.94
EPS, diluted	2.24	0.85	2.97	3.08	4.55	2.41	3.07	3.71	4.34	5.83
Shares, basic (weighted)	4,115	4,121	3,634	3,211	2,945	2,700	2,696	2,744	2,789	2,860
Shares, diluted (weighted)	4,217	4,238	3,732	3,294	3,022	2,786	2,766	2,823	2,866	2,914
Dividend per share	0.64	0.76	0.81	0.96	1.04	1.28	1.36	1.60	1.70	2.00

Balance sheet

	FY2017	FY2018	FY2019	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025	FY2026
Cash and equivalents	21,784	21,620	20,514	37,239	30,098	21,383	9,765	10,454	10,786	31,289
Short-term investments		45,641	17,313	5,818	16,456	519	422	207	417	605
Receivables	5,300	5,136	5,134	5,551	5,409	5,953	6,915	7,874	8,558	10,385
Inventory	300	398	320	211	142	314	298	334	303
Other current assets	3,137	3,762	3,425	3,532	3,604	3,778	3,902	4,019	4,818	4,288
Total current assets	74,515	76,159	46,386	52,140	55,567	31,633	21,004	22,554	24,579	46,567
Property, plant and equipment	5,315	5,897	6,252	6,244	7,049	9,716	17,069	21,536	43,522	99,957
Lease right-of-use assets				2,000	2,600	3,500	4,600	7,290	13,145	29,690
Goodwill	43,045	43,755	43,779	43,769	43,935	43,811	62,261	62,230	62,207	62,261
Intangible assets	7,679	6,670	5,279	3,738	2,430	1,440	9,837	6,890	4,587	3,229
Other non-current assets	3,294	3,975	4,317	6,295	8,490	9,915	11,987	15,493	13,031	11,743
Total assets	134,991	137,851	108,709	115,438	131,107	109,297	134,384	140,976	168,361	261,759
Accounts payable	599	529	580	637	745	1,317	1,204	2,357	5,113	10,977
Accrued liabilities	1,966	1,806	1,628	1,453	2,017	1,944	2,053	1,916	2,243	2,225
Deferred revenue	8,233	8,341	8,374	8,002	8,775	8,357	8,970	9,313	9,387	9,916
Short-term debt	9,797	4,491	4,494	2,371	8,250	3,749	4,061	10,605	7,271	7,199
Total current liabilities	24,178	19,124	18,630	17,200	24,164	19,511	23,090	31,544	32,643	41,764
Long-term debt	48,112	56,128	51,673	69,226	75,995	72,110	86,420	76,264	85,297	122,342
Lease liabilities				1,500	2,100	2,900	4,000	6,255	11,536	26,648
Other non-current liabilities	2,774	2,297	2,748	3,791	4,787	5,203	6,469	6,857	7,647	16,178
Total liabilities	79,861	90,978	86,346	102,721	125,155	115,065	132,828	131,737	147,392	218,703
Total debt						0
Paid-in capital	27,065	28,950	26,909	26,486	26,533	26,808	30,215	32,764	37,107	43,243
Retained earnings	27,598	19,111	-3,496	-12,696	-20,120	-31,336	-27,620	-22,628	-15,481	-4,309
Other comprehensive income	-803	-1,689	-1,628	-1,716	-1,175	-1,692	-1,522	-1,432	-1,175	-1,380
Shareholders' equity	53,860	46,372	21,785	12,074	5,238	-6,220	1,073	8,704	20,451	42,508
Minority interests	386	501	578	643	714	452	483	535	518	548
Total equity	55,130	46,873	22,363	12,717	5,952	-5,768	1,556	9,239	20,969	43,056
Total liabilities and equity	134,991	137,851	108,709	115,438	131,107	109,297	134,384	140,976	168,361	261,759
Shares outstanding	4,137	3,997	3,359	3,067	2,814	2,665	2,713	2,755	2,807	2,880

Cash flow statement

	FY2017	FY2018	FY2019	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025	FY2026
Net income	9,570	3,722	11,235	10,299	13,926	6,901	8,668	10,653	12,627	17,309
Depreciation and amortization	1,000	1,165	1,230	1,382	1,537	1,972	2,526	3,129	3,867	7,623
Stock-based compensation	1,350	1,607	1,653	1,590	1,837	2,613	3,547	3,974	4,674	4,811
Deferred income tax	-440	-847	-1,191	-851	-2,425	-1,146	-2,167	-2,139	-1,637	-917
Change in receivables	-67	267	-272	-445	333	-874	-151	-965	-653	-2,190
Change in inventory	-88
Cash from operations	14,126	15,386	14,551	13,139	15,887	9,539	17,165	18,673	20,821	31,977
Capital expenditures	-2,021	-1,736	-1,660	-1,564	-2,135	-4,511	-8,695	-6,866	-21,215	-55,663
Acquisitions	-11,221	-1,724	-363	-124	-41	-148	-27,721	-63	0
Purchases of investments	-25,867	-25,282	-1,400	-5,731	-37,982	-10,272	-1,181	-1,066	-1,272	-2,039
Sales and maturities of investments	17,615	23,117	12,681	4,687	26,024	19,788
Cash from investing	-21,494	-5,625	26,557	9,843	-13,098	11,220	-36,484	-7,360	-21,711	-51,854
Debt issued	17,732				14,934	0	33,494	0	19,548	46,093
Debt repaid	-4,094	-9,800	-4,500	-4,500	-2,631	-8,250	-21,050	-3,500	-15,841	-6,942
Stock issued	2,181	2,402	2,155	1,588	1,786	482	1,192	742	653	1,449
Share buybacks	-3,561	-11,347	-36,140	-19,240	-20,934	-16,248	-1,300	-1,202	-600	-95
Dividends paid	-2,631	-3,140	-2,932	-3,070	-3,063	-3,457	-3,668	-4,391	-4,743	-5,787
Cash from financing	9,086	-9,982	-42,056	-6,132	-10,378	-29,126	7,910	-10,554	1,098	40,284
Exchange rate effect	-86	57
Net change in cash	1,632	-164	-1,106	16,725	-7,141	-8,715	-11,618	689	332	20,503
Free cash flow	12,105	13,650	12,891	11,575	13,752	5,028	8,470	11,807	-394	-23,686
Interest paid	1,612	1,910	2,059	1,972	2,408	2,735	3,250	3,655	3,374	3,896
Income taxes paid	1,983	1,562	2,901	3,218	3,189	2,567	3,009	3,560	4,020	3,704

Key metrics

Worked out from the statements above. Latest values use the trailing twelve months to August 31, 2026; growth uses fiscal years. Valuation uses the share price of $137.10 on September 25, 2026.

Profitability

Metric	Value	How it is calculated
Operating margin	32.1%	Operating income / revenue.
EBITDA margin	45.3%	EBITDA (operating income + depreciation and amortization) / revenue.
Net margin	26.4%	Net income / revenue.
FCF margin	-40.0%	Free cash flow (cash from operations - capital expenditures) / revenue.
Operating cash flow margin	65.4%	Cash from operations / revenue.
Return on equity (ROE)	28.3%	Net income / average shareholders' equity (opening and closing). Not shown when equity is negative.
Return on assets (ROA)	6.2%	Net income / average total assets.
Return on invested capital (ROIC)	59.9%	Approximation: operating income x (1 - tax rate) / average (total debt + equity - cash). Tax rate is the effective rate when between 0% and 50%, else 21%.
R&D / revenue	14.2%	Research and development expense / revenue.
Stock-based pay / revenue	6.7%	Stock-based compensation (from the cash flow statement) / revenue.
Capex / revenue	105.4%	Capital expenditures / revenue.
D&A / revenue	13.1%	Depreciation and amortization / revenue.

Growth

Metric	Value	How it is calculated
Revenue growth, 1y	17.3%	Revenue vs the same period a year earlier. Only from a positive base.
Revenue CAGR, 3y	10.5%	Compound annual growth of revenue over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Revenue CAGR, 5y	10.7%	Compound annual growth of revenue over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Operating income growth, 1y	16.6%	Operating income vs the same period a year earlier. Only from a positive base.
Operating income CAGR, 3y	16.3%	Compound annual growth of operating income over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Operating income CAGR, 5y	6.3%	Compound annual growth of operating income over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
EBITDA growth, 1y	31.0%	EBITDA vs the same period a year earlier. Only from a positive base.
EBITDA CAGR, 3y	21.8%	Compound annual growth of ebitda over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
EBITDA CAGR, 5y	11.0%	Compound annual growth of ebitda over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Net income growth, 1y	37.3%	Net income vs the same period a year earlier. Only from a positive base.
Net income CAGR, 3y	26.2%	Compound annual growth of net income over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Net income CAGR, 5y	4.4%	Compound annual growth of net income over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
EPS growth, 1y	34.3%	EPS vs the same period a year earlier. Only from a positive base.
EPS CAGR, 3y	23.8%	Compound annual growth of eps over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
EPS CAGR, 5y	5.1%	Compound annual growth of eps over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Operating cash flow growth, 1y	53.6%	Operating cash flow vs the same period a year earlier. Only from a positive base.
Operating cash flow CAGR, 3y	23.0%	Compound annual growth of operating cash flow over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Operating cash flow CAGR, 5y	15.0%	Compound annual growth of operating cash flow over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Dividend per share growth, 1y	17.6%	Dividend per share vs the same period a year earlier. Only from a positive base.
Dividend per share CAGR, 3y	13.7%	Compound annual growth of dividend per share over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Dividend per share CAGR, 5y	14.0%	Compound annual growth of dividend per share over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Book value growth, 1y	107.9%	Book value vs the same period a year earlier. Only from a positive base.
Book value CAGR, 3y	240.9%	Compound annual growth of book value over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Book value CAGR, 5y	52.0%	Compound annual growth of book value over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Total assets growth, 1y	55.5%	Total assets vs the same period a year earlier. Only from a positive base.
Total assets CAGR, 3y	24.9%	Compound annual growth of total assets over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Total assets CAGR, 5y	14.8%	Compound annual growth of total assets over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Share count change, 1y	1.7%	Change in diluted weighted shares vs a year earlier. Negative means buybacks shrank the share count; positive means dilution.
Share count change per year, 3y	1.8%	Change in diluted weighted shares, per year over 3 years. Negative means buybacks shrank the share count; positive means dilution.
Share count change per year, 5y	-0.7%	Change in diluted weighted shares, per year over 5 years. Negative means buybacks shrank the share count; positive means dilution.

Balance sheet health

Metric	Value	How it is calculated
Current ratio	1.17x	Current assets / current liabilities.
Quick ratio	1.02x	(Cash + short-term investments + receivables) / current liabilities.
Cash ratio	0.78x	(Cash + short-term investments) / current liabilities.
Liabilities / assets	77.8%	Total liabilities / total assets.
Interest coverage	4.52x	Operating income / interest expense.
Working capital	$8.12B	Current assets - current liabilities.
Goodwill and intangibles / assets	20.5%	(Goodwill + intangible assets) / total assets.
Tangible book value	$4.51B	Shareholders' equity - goodwill - intangible assets.

Efficiency

Metric	Value	How it is calculated
Asset turnover	0.24x	Revenue / average total assets.
Fixed asset turnover	0.56x	Revenue / average property, plant and equipment.
Receivables turnover	6.30x	Revenue / average receivables.
Days sales outstanding	58 days	365 x average receivables / revenue.
FCF conversion	-151.8%	Free cash flow / net income, when net income is positive.
Capex / operating cash flow	161.2%	Capital expenditures / cash from operations, when that is positive.

Per share

Metric	Value	How it is calculated
EPS, diluted	$6.31	Net income per diluted share, as reported (split-adjusted). Over the last twelve months: the four quarters summed, or net income / latest diluted shares when a quarter has no reported EPS.
Revenue per share	$23.93	Revenue / diluted weighted shares.
FCF per share	-$9.57	Free cash flow / diluted weighted shares.
Operating cash flow per share	$15.65	Cash from operations / diluted weighted shares.
Book value per share	$22.08	Shareholders' equity / shares outstanding (diluted weighted shares when not reported).
Tangible book per share	$1.49	Tangible book value / shares outstanding.
Cash per share	$12.26	(Cash + short-term investments) / shares outstanding.
Payout ratio	31.4%	Dividends paid / net income, when net income is positive.

Valuation

Metric	Value	How it is calculated
Market cap	$394.91B	Share price x shares outstanding.
Enterprise value	$357.84B	Market cap + total debt - cash - short-term investments.
P/E	20.9x	Market cap / net income. Only when net income is positive.
P/S	5.50x	Market cap / revenue.
P/B	5.91x	Market cap / shareholders' equity. Only when equity is positive.
Price / tangible book	87.7x	Market cap / tangible book value, when positive.
P/OCF	8.41x	Market cap / cash from operations, when positive.
EV/Sales	4.99x	Enterprise value / revenue.
EV/EBIT	15.5x	Enterprise value / operating income, when both are positive.
EV/EBITDA	11.0x	Enterprise value / EBITDA, when both are positive.
FCF yield	-7.3%	Free cash flow / market cap.
Earnings yield	4.8%	Net income / market cap (the inverse of P/E).
Dividend yield	1.5%	Dividends paid over the period / market cap.
Shareholder yield	1.5%	(Dividends paid + share buybacks) / market cap.
PEG	0.88x	P/E / EPS growth per year over 3 years (in percent). Only when both are positive.

What was ORACLE CORP's revenue in fiscal 2026?

ORACLE CORP reported revenue of $67.36B for fiscal 2026, 17.3% higher than the year before.

Was ORACLE CORP profitable in fiscal 2026?

Yes. Net income was $17.09B, a net margin of 25.4%.

How much free cash flow did ORACLE CORP generate in fiscal 2026?

Cash from operations of $31.98B minus capital expenditures of $55.66B left free cash flow of -$23.69B.

Source: SEC EDGAR XBRL company facts. Where a company tags only year-to-date figures, quarters are worked out as differences. Where a line is not tagged it is left empty, never estimated.

Open interactive statements, quarterly figures and charts

Back to ORACLE CORP